Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart AssociationMatthew J. Feinstein, Wendy S. Post, Priscilla Y. Hsue et al.|Circulation|2019Cited by 639
Pitavastatin to Prevent Cardiovascular Disease in HIV InfectionSteven Grinspoon, Pamela S. Douglas, Judith A. Aberg et al.|New England Journal of Medicine|2023Cited by 447
Management of Metabolic Complications Associated With Antiretroviral Therapy for HIV-1 Infection: Recommendations of an International AIDS Society–USA PanelMorris Schambelan, Michael S. Saag, Constance A. Benson et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002Cited by 382
Early Outpatient Treatment for Covid-19 with Convalescent PlasmaDavid Sullivan, David Shade, Kelly A. Gebo et al.|New England Journal of Medicine|2022Cited by 269
Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor–Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1Jeffrey L. Lennox, Raphael J. Landovitz, Heather J. Ribaudo et al.|Annals of Internal Medicine|2014Cited by 260